1. Home
  2. VKTX vs KD Comparison

VKTX vs KD Comparison

Compare VKTX & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$28.75

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

HOLD

Current Price

$11.70

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VKTX
KD
Founded
2012
2020
Country
United States
United States
Employees
N/A
80000
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
VKTX
KD
Price
$28.75
$11.70
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
$95.86
$25.92
AVG Volume (30 Days)
1.9M
3.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.85
Revenue
N/A
$15,092,000,000.00
Revenue This Year
N/A
$3.73
Revenue Next Year
N/A
$0.08
P/E Ratio
N/A
$13.27
Revenue Growth
N/A
0.23
52 Week Low
$22.96
$10.10
52 Week High
$43.15
$43.74

Technical Indicators

Market Signals
Indicator
VKTX
KD
Relative Strength Index (RSI) 43.67 43.13
Support Level $25.77 $11.11
Resistance Level $32.92 $13.81
Average True Range (ATR) 1.29 0.52
MACD -0.11 -0.03
Stochastic Oscillator 30.67 31.77

Price Performance

Historical Comparison
VKTX
KD

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

Share on Social Networks: